AAA
Affinity Asset Advisors’s NewAmsterdam Pharma Company N.V. Warrant NAMSW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.96M | Buy |
245,000
+3,043
| +1% | +$24.3K | 0.27% | 53 |
|
|
2025
Q1 | $2.75M | Buy |
241,957
+4,022
| +2% | +$45.7K | 0.26% | 46 |
|
|
2024
Q4 | $3.33M | Buy |
237,935
+24,961
| +12% | +$349K | 0.45% | 41 |
|
|
2024
Q3 | $1.49M | Buy |
212,974
+10,375
| +5% | +$72.6K | 0.2% | 59 |
|
|
2024
Q2 | $1.92M | Hold |
202,599
| – | – | 0.22% | 60 |
|
|
2024
Q1 | $2.24M | Buy |
202,599
+65,599
| +48% | +$724K | 0.28% | 58 |
|
|
2023
Q4 | $429K | Hold |
137,000
| – | – | 0.08% | 66 |
|
|
2023
Q3 | $260K | Buy |
137,000
+100,000
| +270% | +$190K | 0.07% | 66 |
|
|
2023
Q2 | $77.3K | Hold |
37,000
| – | – | 0.03% | 61 |
|
|
2023
Q1 | $68.5K | Buy |
+37,000
| New | +$68.5K | 0.02% | 60 |
|